A Meta-Analysis of Adalimumab for Fistula in Crohn’s Disease

<div>(a) The forest plot of Partial respone rate of ADA treatment on CD with fistula. (b) Sensitivity analysis of high heterogeneity about partial respone rate of ADA treatment on CD with fistula.</div>

Gastroenterology Research and Practice

fig3

Figure 3

Figure 3: A Meta-Analysis of Adalimumab for Fistula in Crohn’s Disease 